Respiratory infections:
the healthcare management

Respiratory infections affect millions of people worldwide annually, causing significant illness and death. According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), respiratory infections are the most deadly communicable diseases worldwide. Influenza alone leads to 9-41 million hospitalizations and 290-650 thousand deaths globally each year.

1

Reliable prediction of the infection’s course remains challenging. The primary focus is still on considering the risk factors that influence care and treatment.

2

Strong immune response can cause more harm than the infection itself, leading to serious conditions such as pneumonia, cytokine storm, sepsis, circulatory shock, multiple organ dysfunction syndrome, and potentially death.

3

Laboratory and point-of-care testing (POCT) diagnostics are used to measure the presence of pathogens. However, commonly used blood protein markers such as CRP, IL-6, SAA1, and PCT are not sufficient for predicting severity.

Unmet Need and Our Solution

Recognizing an immune response quickly can help stop serious health issues from developing.

We found a way to identify people who are at high risk of getting very sick from any respiratory infection.

We have discovered a pioneering universal biomarker capable of predicting individuals at heightened risk of severe health complications resulting from respiratory infections. This breakthrough has the potential to fundamentally transform how we approach risk assessment and treatment for respiratory conditions.